233 related articles for article (PubMed ID: 22451662)
1. Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis.
Liu C; Bai Y; Chen Y; Wang Y; Sottejeau Y; Liu L; Li X; Lingrel JB; Malhotra D; Cooper CJ; Shapiro JI; Xie ZJ; Tian J
J Biol Chem; 2012 May; 287(20):16390-8. PubMed ID: 22451662
[TBL] [Abstract][Full Text] [Related]
2. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes.
Liu L; Zhao X; Pierre SV; Askari A
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1489-97. PubMed ID: 17728397
[TBL] [Abstract][Full Text] [Related]
3. Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase.
Wansapura AN; Lasko V; Xie Z; Fedorova OV; Bagrov AY; Lingrel JB; Lorenz JN
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1833-9. PubMed ID: 19376809
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice.
Drummond CA; Sayed M; Evans KL; Shi H; Wang X; Haller ST; Liu J; Cooper CJ; Xie Z; Shapiro JI; Tian J
Am J Physiol Heart Circ Physiol; 2014 Jun; 306(12):H1631-43. PubMed ID: 24748592
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling.
Haller ST; Yan Y; Drummond CA; Xie J; Tian J; Kennedy DJ; Shilova VY; Xie Z; Liu J; Cooper CJ; Malhotra D; Shapiro JI; Fedorova OV; Bagrov AY
J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27694325
[TBL] [Abstract][Full Text] [Related]
6. Na+/K+-ATPase inhibition by ouabain induces CaMKII-dependent apoptosis in adult rat cardiac myocytes.
Sapia L; Palomeque J; Mattiazzi A; Petroff MV
J Mol Cell Cardiol; 2010 Sep; 49(3):459-68. PubMed ID: 20435043
[TBL] [Abstract][Full Text] [Related]
7. The involvement of Akt, mTOR, and S6K in the in vivo effect of IGF-1 on the regulation of rat cardiac Na
Banjac K; Obradovic M; Zafirovic S; Essack M; Gluvic Z; Sunderic M; Nedic O; Isenovic ER
Mol Biol Rep; 2024 Apr; 51(1):517. PubMed ID: 38622478
[TBL] [Abstract][Full Text] [Related]
8. Changes in sodium pump expression dictate the effects of ouabain on cell growth.
Tian J; Li X; Liang M; Liu L; Xie JX; Ye Q; Kometiani P; Tillekeratne M; Jin R; Xie Z
J Biol Chem; 2009 May; 284(22):14921-9. PubMed ID: 19329430
[TBL] [Abstract][Full Text] [Related]
9. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
[TBL] [Abstract][Full Text] [Related]
10. Na(+)/K)+)-ATPase α2-isoform preferentially modulates Ca2(+) transients and sarcoplasmic reticulum Ca2(+) release in cardiac myocytes.
Despa S; Lingrel JB; Bers DM
Cardiovasc Res; 2012 Sep; 95(4):480-6. PubMed ID: 22739122
[TBL] [Abstract][Full Text] [Related]
11. Na/K-ATPase signaling mediates miR-29b-3p regulation and cardiac fibrosis formation in mice with chronic kidney disease.
Drummond CA; Fan X; Haller ST; Kennedy DJ; Liu J; Tian J
PLoS One; 2018; 13(5):e0197688. PubMed ID: 29775473
[TBL] [Abstract][Full Text] [Related]
12. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
[TBL] [Abstract][Full Text] [Related]
13. Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function.
Uddin MN; Horvat D; Glaser SS; Mitchell BM; Puschett JB
J Biol Chem; 2008 Jun; 283(26):17946-53. PubMed ID: 18434301
[TBL] [Abstract][Full Text] [Related]
14. Expression of rat Na-K-ATPase α2 enables ion pumping but not ouabain-induced signaling in α1-deficient porcine renal epithelial cells.
Xie J; Ye Q; Cui X; Madan N; Yi Q; Pierre SV; Xie Z
Am J Physiol Cell Physiol; 2015 Sep; 309(6):C373-82. PubMed ID: 26108663
[TBL] [Abstract][Full Text] [Related]
15. Identification of a mutant α1 Na/K-ATPase that pumps but is defective in signal transduction.
Lai F; Madan N; Ye Q; Duan Q; Li Z; Wang S; Si S; Xie Z
J Biol Chem; 2013 May; 288(19):13295-304. PubMed ID: 23532853
[TBL] [Abstract][Full Text] [Related]
16. New bufadienolides extracted from Rhinella marina inhibit Na,K-ATPase and induce apoptosis by activating caspases 3 and 9 in human breast and ovarian cancer cells.
Garcia IJP; de Oliveira GC; de Moura Valadares JM; Banfi FF; Andrade SN; Freitas TR; Dos Santos Monção Filho E; Lima Santos H; Júnior GMV; Chaves MH; de Jesus Rodrigues D; Sanchez BAM; Varotti FP; Barbosa LA
Steroids; 2019 Dec; 152():108490. PubMed ID: 31499071
[TBL] [Abstract][Full Text] [Related]
17. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cardiac myocyte contractility by phospholemman: Na+/Ca2+ exchange versus Na+ -K+ -ATPase.
Song J; Zhang XQ; Wang J; Cheskis E; Chan TO; Feldman AM; Tucker AL; Cheung JY
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1615-25. PubMed ID: 18708446
[TBL] [Abstract][Full Text] [Related]
19. Cell signaling associated with Na(+)/K(+)-ATPase: activation of phosphatidylinositide 3-kinase IA/Akt by ouabain is independent of Src.
Wu J; Akkuratov EE; Bai Y; Gaskill CM; Askari A; Liu L
Biochemistry; 2013 Dec; 52(50):9059-67. PubMed ID: 24266852
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Na/K-ATPase in hydrogen peroxide-induced activation of the Src/ERK pathway in LLC-PK1 cells.
Wang Y; Ye Q; Liu C; Xie JX; Yan Y; Lai F; Duan Q; Li X; Tian J; Xie Z
Free Radic Biol Med; 2014 Jun; 71():415-426. PubMed ID: 24703895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
